<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//ionctura.threethirtystudio.co.uk/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/the-biology-of-roginolisib-activity-without-immune-toxicity/</loc>
		<lastmod>2026-01-30T14:02:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/end-of-year-reflections-from-our-ceo/</loc>
		<lastmod>2025-12-19T12:52:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/addressing-drug-resistance-in-non-small-cell-lung-cancer/</loc>
		<lastmod>2025-12-12T11:08:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/ionctura-enhances-board-to-accelerate-growth-and-innovation/</loc>
		<lastmod>2025-12-12T11:07:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/ionctura-expands-roginolisib-trials-to-the-us/</loc>
		<lastmod>2025-12-12T11:07:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/whats-next-for-cambritaxestat/</loc>
		<lastmod>2025-12-12T11:07:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/driving-breakthroughs-for-myelofibrosis-care/</loc>
		<lastmod>2025-12-12T11:05:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/realizing-the-potential-of-pi3k%ce%b4-inhibitors-in-peripheral-t-cell-lymphomas/</loc>
		<lastmod>2025-09-15T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/scientific-innovation-in-uveal-melanoma/</loc>
		<lastmod>2025-05-23T15:31:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/opportunities-and-challenges-in-immunotherapy/</loc>
		<lastmod>2025-02-06T09:07:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/pancreatic-cancer-advances/</loc>
		<lastmod>2025-02-04T16:59:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/reflections-from-our-ceo/</loc>
		<lastmod>2024-12-20T08:50:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/a-note-from-our-ceo/</loc>
		<lastmod>2024-12-12T09:02:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/pi3k%ce%b4-inhibitors-offer-promise-in-solid-tumors/</loc>
		<lastmod>2024-11-20T22:07:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/realising-the-potential-of-autotaxin-therapy-in-cancer/</loc>
		<lastmod>2024-07-15T09:53:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/giusy-di-conza-shines-a-light-on-innovation-in-drug-discovery/</loc>
		<lastmod>2024-07-05T12:50:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://ionctura.threethirtystudio.co.uk/insight/emerging-therapies-offer-hope-for-uveal-melanoma-patients/</loc>
		<lastmod>2024-07-02T10:00:23+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->